Tapewire
HeatmapsAnalyticsCompareCompaniesCountriesGovernment bodiesPeopleETFsSectorsIndustriesWatchlistPortfolioTerminalScreenerBrokersToolsLearnGlossaryMethodologyAPIPricing

Adaptive Biotechnologies Corp — insider transactions

45 transactions on record · ADPT · CIK 1478320

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
45
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
7
Bought, 3m
$0
Sold, 3m
$52.1M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$8M
2026-08-17
Director share, 12m
40.0%
of transactions where role is stated
Current run
45 sells
consecutive same-direction transactions
Net 3m flow
-$52.1M
purchases minus sales
Total on record
45

Transactions

45 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative15,629$3.99$62.4Kfiling
2026-09-182026-09-162LO FRANCISChief People OfficerOpen market sale7,869$28.57$224.8Kfiling
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative15,629$0.00—filing
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative13,398$8.46$113.3Kfiling
2026-09-182026-09-162LO FRANCISChief People OfficerOpen market sale107,537$28.02$3Mfiling
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative13,398$0.00—filing
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative53,091$12.14$644.5Kfiling
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative23,442$8.12$190.3Kfiling
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative53,091$0.00—filing
2026-09-182026-09-162LO FRANCISChief People OfficerExercise of derivative23,442$0.00—filing
2026-09-172026-09-152BOBULSKY SUSANChief Commercial Officer, MRDOpen market sale1,195$27.00$32.3Kfiling
2026-08-282026-08-262OWEN KATEY EINTERZDirectorOpen market sale9,615$26.00$250Kfiling
2026-08-202026-08-182HERSHBERG ROBERTDirectorOpen market sale15,664$24.41$382.4Kfiling
2026-08-202026-08-182HERSHBERG ROBERTDirectorExercise of derivative15,000$6.32$94.8Kfiling
2026-08-202026-08-182HERSHBERG ROBERTDirectorOpen market sale15,000$24.39$365.9Kfiling
2026-08-202026-08-182HERSHBERG ROBERTDirectorExercise of derivative15,000$0.00—filing
2026-08-192026-08-172NEUPERT PETER MDirectorOpen market sale15,000$25.23$378.5Kfiling
2026-08-192026-08-172NEUPERT PETER MDirectorExercise of derivative15,000$0.00—filing
2026-08-192026-08-172NEUPERT PETER MDirectorOpen market sale40,000$25.10$1Mfiling
2026-08-192026-08-172ROBINS CHAD MDirector, CEO and ChairmanExercise of derivative321,324$6.55$2.1Mfiling
2026-08-192026-08-181ROBINS CHAD MDirector, CEO and ChairmanExercise of derivative278,676$6.55$1.8Mfiling
2026-08-192026-08-172ROBINS CHAD MDirector, CEO and ChairmanExercise of derivative321,324$0.00—filing
2026-08-192026-08-172NEUPERT PETER MDirectorExercise of derivative15,000$6.32$94.8Kfiling
2026-08-192026-08-172NEUPERT PETER MDirectorOpen market sale69,690$25.16$1.8Mfiling
2026-08-192026-08-172ROBINS CHAD MDirector, CEO and ChairmanOpen market sale318,799$25.08$8Mfiling
2026-08-192026-08-181ROBINS CHAD MDirector, CEO and ChairmanOpen market sale278,472$24.48$6.8Mfiling
2026-08-192026-08-181ROBINS CHAD MDirector, CEO and ChairmanExercise of derivative278,676$0.00—filing
2026-08-192026-08-172ROBINS CHAD MDirector, CEO and ChairmanOpen market sale2,525$25.57$64.6Kfiling
2026-08-192026-08-181ROBINS CHAD MDirector, CEO and ChairmanOpen market sale204$25.14$5.1Kfiling
2026-08-122026-08-102BOBULSKY SUSANChief Commercial Officer, MRDOpen market sale3,000$25.00$75Kfiling
2026-08-032026-07-304BOBULSKY SUSANChief Commercial Officer, MRDOpen market sale1,299$24.00$31.2Kfiling
2026-07-232026-07-212ROBINS HARLAN SChief Scientific OfficerExercise of derivative284,800$6.55$1.9Mfiling
2026-07-232026-07-212ROBINS HARLAN SChief Scientific OfficerOpen market sale213,702$22.12$4.7Mfiling
2026-07-232026-07-212ROBINS HARLAN SChief Scientific OfficerOpen market sale278,698$21.72$6.1Mfiling
2026-07-232026-07-212ROBINS HARLAN SChief Scientific OfficerExercise of derivative284,800$0.00—filing
2026-07-202026-07-164BOBULSKY SUSANChief Commercial Officer, MRDOpen market sale5,000$23.00$115Kfiling
2026-07-172026-07-152LO FRANCISChief People OfficerExercise of derivative22,711$8.46$192.1Kfiling
2026-07-172026-07-152LO FRANCISChief People OfficerExercise of derivative23,677$0.00—filing
2026-07-172026-07-152LO FRANCISChief People OfficerExercise of derivative59,374$7.80$463.1Kfiling
2026-07-172026-07-152LO FRANCISChief People OfficerOpen market sale105,762$22.59$2.4Mfiling
2026-07-172026-07-152LO FRANCISChief People OfficerExercise of derivative22,711$0.00—filing
2026-07-172026-07-152LO FRANCISChief People OfficerExercise of derivative23,677$12.14$287.4Kfiling
2026-07-172026-07-152LO FRANCISChief People OfficerExercise of derivative59,374$0.00—filing
2026-07-072026-07-025ROBINS HARLAN SChief Scientific OfficerOpen market sale146,889$22.45$3.3Mfiling
2026-07-072026-07-025ROBINS HARLAN SChief Scientific OfficerOpen market sale239,351$21.74$5.2Mfiling

Source: U.S. Securities and Exchange Commission, EDGAR